These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6840814)

  • 21. Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo.
    Romani L; Puccetti P; Fioretti MC; Mage MG
    Int J Cancer; 1985 Aug; 36(2):225-31. PubMed ID: 3894248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of anti-tumour immunity in syngeneic mice by a leukaemic cell line.
    Mongini C; Waldner CI; Alvarez E; Roig MI; Sánchez Lockhart M; Gravisaco MJ; Hajos SE
    Scand J Immunol; 1995 Mar; 41(3):298-304. PubMed ID: 7871391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of the natural humoral anti-tumor immune response in mice as shown by monoclonal antibodies.
    Colnaghi MI; Menard S; Tagliabue E; Torre GD
    J Immunol; 1982 Jun; 128(6):2757-62. PubMed ID: 6896209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein.
    Freedman PM; Autry JR; Tokuda S; Williams RC
    J Natl Cancer Inst; 1976 Apr; 56(4):735-40. PubMed ID: 56452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. II. Characterization of the cell populations involved in its production and release.
    Hollander N; Iskov N; Segal S; Feldman M
    Int J Cancer; 1978 Oct; 22(4):471-8. PubMed ID: 359491
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular and humoral immunity after allogeneic transplantation in the rat. I. Cellular and humoral immunity of measured by a 51 Cr cytotoxicity assay after allogeneic tumor and renal transplantation.
    Biesecker JL
    Transplantation; 1973 Mar; 15(3):298-307. PubMed ID: 4576040
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells.
    Zhang XY; Liu XG; Wang W; Wang WC; Gao XM
    Immunology; 2003 Apr; 108(4):465-73. PubMed ID: 12667208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
    Nicolin A; Bini A; Franco P; Goldin A
    Cancer Chemother Rep; 1974; 58(3):325-30. PubMed ID: 4841716
    [No Abstract]   [Full Text] [Related]  

  • 29. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
    Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
    J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and humoral immune responses of mice during immunological enhancement of an allogeneic tumor.
    Giorgi JV; Tokuda S; Goldberg EH; Shen FW
    Transplantation; 1978 Mar; 25(3):152-7. PubMed ID: 644650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulatory effects of accessory cells on the generation of cell-mediated immune reactions.
    Miller CL; Mishell RI
    J Immunol; 1975 Feb; 114(2 Pt 1):692-5. PubMed ID: 1091702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E; Otiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of increased graft-versus-host disease by mouse spleen cells sensitized in vitro to allogeneic tumor.
    Einstein AB; Cheever MA; Fefer A
    Transplantation; 1976 Dec; 22(6):589-94. PubMed ID: 12600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo resistance and in vitro cellular reactivity against lymphosarcoma cells in immunized mice.
    Colnaghi MI; Ménard S; Pierotti MA
    Tumori; 1978; 64(4):371-82. PubMed ID: 581104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of cytotoxic lymphocytes after various immunizing procedures in a virus-induced non-producer syngeneic system: correlation between in vitro and in vivo lytic activity.
    Pioch Y; Gerber M; Serrou B
    Br J Cancer; 1980 Aug; 42(2):275-83. PubMed ID: 6448617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats.
    Jamasbi RJ; Nettesheim P; Kennel SJ
    Cancer Res; 1978 Feb; 38(2):261-7. PubMed ID: 340026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.